Medical News

RSS

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Juniper Pharmaceuticals, Inc., today announced financial results for the three-month period ended March 31, 2015.

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

Partners congratulate researchers on forming new biotechnology company

The Children's Hospital of Eastern Ontario, The Ottawa Hospital, the University of Ottawa and McMaster University congratulate its researchers on forming Turnstone Biologics Inc., a biotechnology company focused on developing new treatments for cancer that harness the patient's own immune system.

6 May 2015

Researcher reports possible existence of sixth DNA base

DNA (deoxyribonucleic acid) is the main component of our genetic material. It is formed by combining four parts: A, C, G and T (adenine, cytosine, guanine and thymine), called bases of DNA combine in thousands of possible sequences to provide the genetic variability that enables the wealth of aspects and functions of living beings.

6 May 2015

Luxembourg biologists provide complete image of human 'miRNome' in blood samples

In an elaborate study, biologists of the University of Luxembourg have found out that small molecules named microRNAs are, against many hopes, not yet suitable for early diagnosis of skin cancer, as well as supposedly for other types of cancer, in blood samples. For the first time they analysed all microRNAs in the serum of healthy people and thus provided a first complete image of the human "miRNome" in blood samples, in reference to the better-known "genome".

6 May 2015

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of gastric cancers

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted an Orphan Drug Designation (ODD) for its lead product candidate, REOLYSIN, for the treatment of gastric cancers.

6 May 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Transition Therapeutics Inc. today announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") from Eli Lilly and Company.

6 May 2015

Weston Park Hospital offers two cutting-edge treatments for rare cancer tumours, prostate cancer

TWO cutting-edge cancer treatments using targeted radioactive therapy injections to destroy cancer cells are now being offered to patients with rare neuroendocrine tumours and patients with prostate cancer at Weston Park Hospital.

6 May 2015

First patient receives new 'resistance-busting' experimental skin cancer drug

A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor - a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.

6 May 2015

BYU researchers shed new light on why people tend to snack at night

After gobbling the fourth Oreo in a row while bathed in refrigerator light, have you ever thought, "That wasn't enough," and then proceeded to search for something more? Researchers at BYU have shed new light on why you, your friends, neighbors and most everyone you know tend to snack at night: some areas of the brain don't get the same "food high" in the evening.

6 May 2015

New MGH-developed technology may extend benefits of MRI in patients with implanted devices

New technology developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital may extend the benefits of magnetic resonance imaging (MRI) to many patients whose access to MRI is currently limited.

6 May 2015

Scientists identify mechanism that explains how some stem cells get new identity

Scientists at the University of Copenhagen have identified one mechanism that explains how some stem cells choose to become a given cell type: the cells combine specific sets of proteins at precise positions along the DNA. When these particular groups of proteins are combined, the gates are opened so that certain groups of genes can now be used, giving the cells a new identity.

6 May 2015

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.

6 May 2015

New health-focused code school coming to Chicago

The newest code school in Chicago, CodeAbode, starts classes on June 1. CodeAbode offers "boot camp" and part-time options designed to turn students into web and mobile app developers.

6 May 2015

Automated PoCyton cytometer effective for counting cancer cells

Biological and medical scientists have been using flow cytometry to count cancer cells for the past 40 years. But the large instruments are expensive and can only be operated by trained personnel. By contrast the PoCyton cytometer developed by Fraunhofer researchers is cheap to produce, no bigger than a shoebox, and automated.

6 May 2015

Study offers new insights into construction of nuclear pores in nuclear envelope

In a recent study, a team of researchers led by Alwin Köhler at the Max F. Perutz Laboratories (MFPL) belonging to the University of Vienna and the Medical University of Vienna offer new insights into how nuclear pores are constructed in the nuclear envelope.

6 May 2015

Diabetic neuropathy highly prevalent among diabetic patients in Romania

A survey of 25,000 Romanians with diabetes has revealed that diabetic neuropathy (DN), a complication of diabetes, is highly prevalent in these patients, even in the absence of a diagnostic, and has an important impact on patients' quality of life.

6 May 2015

NTNU researchers find link between sleep disorders and psychiatric problems in young children

Toddlers who take a long time to fall asleep or wake up many times during the night have put many a desperate mom and dad to the test. Tired parents are often told that night waking is part of toddlerhood, and that it will soon pass on its own, but this is not the case for everyone.

6 May 2015

NEB announces issuance of US patent for RNA-seq technology

New England Biolabs, Inc. announces the issuance of United States Patent Number 8,999,677, which describes a novel method for retaining valuable strand-specific information contained within RNA transcripts.

From New England Biolabs 6 May 2015

Parliamentary Secretary Scott Armstrong encourages health experts to tackle mental health issues in workplaces

On behalf of the Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, Scott Armstrong, Parliamentary Secretary to the Minister of Labour, addressed health and safety experts at the 2015 Light the Way and Chemical Dependency Education and Rehabilitation Program National Conference in Cornwall today.

6 May 2015

Medical News

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Partners congratulate researchers on forming new biotechnology company

Researcher reports possible existence of sixth DNA base

Luxembourg biologists provide complete image of human 'miRNome' in blood samples

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of gastric cancers

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Weston Park Hospital offers two cutting-edge treatments for rare cancer tumours, prostate cancer

First patient receives new 'resistance-busting' experimental skin cancer drug

BYU researchers shed new light on why people tend to snack at night

New MGH-developed technology may extend benefits of MRI in patients with implanted devices

Scientists identify mechanism that explains how some stem cells get new identity

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

New health-focused code school coming to Chicago

Automated PoCyton cytometer effective for counting cancer cells

Study offers new insights into construction of nuclear pores in nuclear envelope

Diabetic neuropathy highly prevalent among diabetic patients in Romania

NTNU researchers find link between sleep disorders and psychiatric problems in young children

NEB announces issuance of US patent for RNA-seq technology

Parliamentary Secretary Scott Armstrong encourages health experts to tackle mental health issues in workplaces

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News